Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Untargeted metabolomics to understand the basis of phenotypic differences in amphotericin B-resistant Leishmania parasites
- Unknown Metabolite Annotation in Mouse Aging using Ion Mobility Collision Cross-Section Atlas (AllCCS)
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Escherichia coli assays)
- Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
- Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Streptococcus pyogenes assays)
- Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
- Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
- Red-Fleshed Apple Anthocyanin Extracts Attenuate Male Reproductive System Dysfunction Caused by Busulfan in Mice (Mouse blood plasma; UPLC-MS/MS assays)
- Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
- Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
- Novel Minor Groove Binders cure animal African trypanosomiasis in an in vivo mouse model
Observed in differential profiles
- G1_Wild_Type_vs_G2_AmBRAcl1
- 36_week_vs_104_week
- RPMI_B36_vs_Pooled_Sera_B36
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- G1_RPMI_modified_Blood_M1T1_5448_vs_G2_Pooled_sera_Blood_M1T1_5448
- Control_vs_nsPEF_7_day
- WT_vs_WT_Aco
- Control_vs_Busulfan_5_mg_kg_RAAE
- G1_PBS_vs_G2_DSS
- Control_0d_vs_Treatment_180d
- MGB234_Treatment_vs_DMSO_Control
- MGB234_Treatment_vs_DMSO_Control